Seoul: The KOSPI 200 index experienced varied movements in stock prices during Tuesday’s trading session on the Korea Stock Exchange. Several companies saw significant changes
Seoul: Samsung Bioepis Co., a biosimilar drug developer under Samsung Group, has announced its approval to market its biosimilar treatment for autoimmune diseases in Japan.
Seoul: South Korean stocks continued their upward trend for the third consecutive session on Tuesday, supported by foreign investment following reduced concerns over an artificial
Seoul: South Korean stocks continued their upward trend for the third consecutive session on Tuesday, supported by foreign investment following reduced concerns over an artificial
Seoul: South Korean stocks opened higher Tuesday, tracking a lift in Wall Street led by a rebound in tech shares. The benchmark Korea Composite Stock
Seoul: South Korean stocks opened higher Tuesday, tracking a lift in Wall Street led by a rebound in tech shares. The benchmark Korea Composite Stock
